Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer

NCT00471120 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-08-05

No results posted yet for this study

Summary

This study aims at developing an accurate, simple, and cost-effective method for screening and early detection of uterine cancers

Conditions

Interventions

OTHER

P2x7 assay

compare P2X7 assay to biopsy

Sponsors & Collaborators

  • Dick Domanik

    lead INDUSTRY

Principal Investigators

  • Jay Pinkerton, MD · University Hospitals Cleveland Medical Center

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2007-04-30
Completion
2008-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00471120 on ClinicalTrials.gov